Abstract
Deep learning (DL)-based prediction of biological age in the developing human from a brain magnetic resonance image (MRI) (“brain age”) may have important diagnostic and therapeutic applications as a non-invasive biomarker of brain health, aging, and neurocognition. While previous deep learning tools for predicting brain age have shown promising capabilities using single-institution, cross-sectional datasets, our work aims to advance the field by leveraging multi-site, longitudinal data with externally validated and independently implementable code to facilitate clinical translation and utility. This builds on prior foundational efforts in brain age modeling to enable broader generalization and individual’s longitudinal brain development. Here, we leveraged 32,851 T1-weighted MRI scans from healthy children and adolescents aged 3 to 30 from 16 multisite datasets to develop and evaluate several DL brain age frameworks, including a novel regression diffusion DL network (AgeDiffuse). In a multisite external validation (5 datasets), we found that AgeDiffuse outperformed conventional DL frameworks, with a mean absolute error (MAE) of 2.78 years (IQR:[1.2-3.9]). In a second, separate external validation (3 datasets), AgeDiffuse yielded an MAE of 1.97 years (IQR: [0.8-2.8]). We found that AgeDiffuse brain age predictions reflected age- related brain structure volume changes better than biological age (R2=0.48 vs R2=0.37). Finally, we found that longitudinal predicted brain age tracked closely with chronological age at the individual level. To enable independent validation and application, we made AgeDiffuse publicly available and usable for the research community.
Highlights
Diffusion regression models trained with a large dataset (AgeDiffuse) enable accurate pediatric brain age prediction.
AgeDiffuse demonstrates relatively stable performance on multiple external validation sets across people aged 3 – 30.
Our pipeline is made publicly accessible, encouraging collaboration and progress in pediatric brain research.
Competing Interest Statement
JS and RAIB hold equity in and serve on the board of Centile Bioscience. All other authors declare no conflict of interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Corrected Authors first name and added ORCID ID
Abbreviations
- DL
- Deep learning
- MRI
- Magnetic resonance imaging
- MAE
- Mean absolute error
- IQR
- Interquartile range 95%
- CI
- 95% confidence interval
- SoTa
- state-of-the-art
- DiffMIC
- dual-guidance diffusion model for medical image classification
- AgeDiffuse
- Novel regression dual-guidance diffusion model for brain age prediction
- VV
- cerebrospinal fluid
- WMV
- white matter volume
- GMV
- gray matter volume
- sGMV
- total subcortical grey matter volume
- CNN
- convolutional neural network
